VitaDAO logo

VitaDAO

North America, Ontario, Canada, Ottawa

Description

A decentralized collective funding early stage aging research & spinning out longevity biotech startups to extend healthy lifespan

Investor Profile

VitaDAO has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • Singapore (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Genetics
  • Insurtech
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does VitaDAO frequently co-invest with?

Infinita Fund
North America, Islas de la Bahia, Honduras, Roatán
Co-Investments: 1
Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
MI
Europe, Limassol, Cyprus, Limassol
Co-Investments: 1
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1

Which angels does VitaDAO often collaborate with?

LL
Europe, Minsk, Belarus, Minsk
Shared Deals: 1
Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
KP
North America, California, United States, San Francisco
Shared Deals: 1
TE
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by VitaDAO?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000
Gero

Singapore, Central Region, Singapore

Gero is a biotechnology company that provides therapeutics against chronic diseases.

Artificial Intelligence (AI)BiotechnologyGeneticsInsurTechPharmaceutical
Series AOct 18, 2023
Amount Raised: $6,000,000